Iradimed Corp (IRMD)
NASDAQ:IRMD
Holding IRMD?
Track your performance easily

Iradimed (IRMD) Income Statement

147 Followers

Iradimed Income Statement

Last quarter (Q3 2024), Iradimed's total revenue was $18.33M, an increase of 11.04% from the same quarter last year. In Q3, Iradimed's net income was $5.05M. See Iradimed’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 71.31M$ 65.56M$ 53.30M$ 41.81M$ 31.72M$ 38.52M
Cost of Revenue
$ 16.30M$ 15.40M$ 12.02M$ -9.76M$ 8.14M$ 8.82M
Gross Profit
$ 55.00M$ 50.16M$ 41.28M$ 32.05M$ 23.57M$ 29.70M
Operating Expense
$ 33.68M$ 30.12M$ 25.65M$ -22.23M$ 24.33M$ 21.05M
Operating Income
$ 21.32M$ 20.04M$ 15.63M$ 9.82M$ -756.09K$ 8.65M
Net Non Operating Interest Income Expense
$ 1.86M$ 1.86M$ 581.85K$ 18.61K$ 132.19K$ 388.80K
Other Income Expense
$ -2.29M$ -161.31K$ -553.10K$ -18.59K$ 139.21K$ 7.11K
Pretax Income
$ 23.61M$ 21.74M$ 16.18M$ 9.84M$ -616.88K$ 9.04M
Tax Provision
$ 4.99M$ 4.55M$ 3.35M$ 510.82K$ -1.99M$ -587.64K
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ 18.63M$ 17.19M$ 12.83M$ 9.33M$ 1.37M$ 9.63M
Basic EPS
$ 1.48$ 1.36$ 1.02$ 0.76$ 0.11$ 0.85
Diluted EPS
$ 1.46$ 1.35$ 1.02$ 0.74$ 0.11$ 0.78
Basic Average Shares
$ 50.62M$ 12.60M$ 12.56M$ 12.35M$ 12.12M$ 11.28M
Diluted Average Shares
$ 51.03M$ 12.72M$ 12.64M$ 12.59M$ 12.44M$ 12.28M
Dividend Per Share
$ 0.15-----
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
----$ 0.40$ 0.85
Rent Expense Supplemental
------
Total Expenses
$ 49.98M$ 45.53M$ 37.68M$ -32.00M$ 32.47M$ 29.87M
Net Income From Continuing And Discontinued Operation
$ 18.63M$ 17.19M$ 12.83M$ 9.33M$ 1.37M$ 9.63M
Normalized Income
$ 17.75M---$ 1.37M$ 9.63M
Interest Expense
------
EBIT
$ 23.61M$ 20.04M$ 16.18M$ 9.84M$ -756.09K$ 8.65M
EBITDA
$ 24.44M$ 20.80M$ 16.85M$ 11.24M$ 582.73K$ 9.89M
Currency in USD

Iradimed Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis